InvestorsHub Logo
Followers 12
Posts 1139
Boards Moderated 0
Alias Born 02/13/2018

Re: None

Sunday, 12/13/2020 10:30:43 PM

Sunday, December 13, 2020 10:30:43 PM

Post# of 233365
Think about where this company is right now. They’ve completed phase 3 enrollment with mortality as the primary outcome! For a therapeutic that would be first in class for a worldwide pandemic....

If this isn’t the most undervalued biotech out there I’ll eat my socks. I cannot believe that this is headline news for the next 30 days. Cytodyn needs to focus on major media markets for the next couple weeks as this could easily be 10x the pps it is now in short order. Think about what they are on the verge of reporting and offering in the fight against Covid
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News